Growth Metrics

Braskem (BAK) Common Equity (2016 - 2025)

Braskem has reported Common Equity over the past 17 years, most recently at -$3.0 billion for Q4 2025.

  • For Q4 2025, Common Equity fell 263.98% year-over-year to -$3.0 billion; the TTM value through Dec 2025 reached -$3.0 billion, down 263.98%, while the annual FY2025 figure was -$3.0 billion, 263.98% down from the prior year.
  • Common Equity for Q4 2025 was -$3.0 billion at Braskem, down from -$822.8 million in the prior quarter.
  • Over five years, Common Equity peaked at $1.2 billion in Q4 2022 and troughed at -$3.0 billion in Q4 2025.
  • A 5-year average of -$176.4 million and a median of $662.3 million in 2023 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: surged 255.35% in 2021 and later crashed 263.98% in 2025.
  • Year by year, Common Equity stood at $1.1 billion in 2021, then increased by 4.37% to $1.2 billion in 2022, then tumbled by 42.95% to $662.3 million in 2023, then crashed by 224.23% to -$822.8 million in 2024, then plummeted by 263.98% to -$3.0 billion in 2025.
  • Business Quant data shows Common Equity for BAK at -$3.0 billion in Q4 2025, -$822.8 million in Q4 2024, and $662.3 million in Q4 2023.